Live search
TopFind is fetching the latest matches for your search.
We reviewed 266 live results for liquid glucagon and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Ivig and Pharmaceutical Services.
Source: Eli Lilly (Singapore) Pte Ltd
Description
Access to unregistered therapeutic products like Baqsimi in the Singapore market is managed through the Special Access Route (SAR) or Named Patient basis. This service involves physician-led requests for medications not currently listed on the standard Health Sciences Authority (HSA) retail market.
Best for
Singapore medical practitioners, patients with specific medical needs and unregistered drug import support
Rating
Source: Takeda Pharmaceuticals
Description
Gammagard Liquid is a 10% liquid immunoglobulin available for both intravenous (IVIG) and subcutaneous (SCIG) administration. It is indicated for PI, Multifocal Motor Neuropathy (MMN), and CIDP. The ERC version features enhanced removal capability for very low IgA content.
Best for
MMN patients, low IgA requirements, dual administration routes and PI therapy
Rating
Source: Takeda Malaysia
Description
An intravenous immunoglobulin treatment approved for the management of Primary Immunodeficiency (PI) and available in liquid form for infusion.
Best for
primary immunodeficiency, antibody replacement and immunology clinics
Rating
| Compare | Special Access Route (SAR) Glucagon Access | Gammagard Liquid / Gammagard Liquid ERC | Gammagard Liquid |
|---|---|---|---|
| Source | Eli Lilly (Singapore) Pte Ltd | Takeda Pharmaceuticals | Takeda Malaysia |
| Description | Access to unregistered therapeutic products like Baqsimi in the Singapore market is managed through the Special Access Route (SAR) or Named Patient basis. This service involves physician-led requests for medications not currently listed on the standard Health Sciences Authority (HSA) retail market. | Gammagard Liquid is a 10% liquid immunoglobulin available for both intravenous (IVIG) and subcutaneous (SCIG) administration. It is indicated for PI, Multifocal Motor Neuropathy (MMN), and CIDP. The ERC version features enhanced removal capability for very low IgA content. | An intravenous immunoglobulin treatment approved for the management of Primary Immunodeficiency (PI) and available in liquid form for infusion. |
| Best for | Singapore medical practitioners, patients with specific medical needs and unregistered drug import support | MMN patients, low IgA requirements, dual administration routes and PI therapy | primary immunodeficiency, antibody replacement and immunology clinics |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
If you want the most balanced option to start with, I recommend:
"Special Access Route (SAR) Glucagon Access from Eli Lilly (Singapore) Pte Ltd."
I picked this because Eli Lilly is a key local contact for diabetes care in Singapore and can provide guidance on specialized access for their therapeutic portfolio.